Oscar Health, Inc.
OSCR · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.22 | 0.03 | -0.01 | -0.03 |
| FCF Yield | -20.14% | 9.20% | 26.39% | 10.52% |
| EV / EBITDA | -34.37 | -14.20 | 4.51 | -14.47 |
| Quality | ||||
| ROIC | -7.21% | -15.05% | 16.25% | -11.13% |
| Gross Margin | -197.93% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 7.02 | -2.23 | 3.19 | -2.26 |
| Growth | ||||
| Revenue 3-Year CAGR | 27.32% | 28.56% | 30.04% | 30.55% |
| Free Cash Flow Growth | -294.81% | -42.52% | 155.74% | 166.97% |
| Safety | ||||
| Net Debt / EBITDA | 14.90 | 10.42 | -6.44 | 8.87 |
| Interest Coverage | -18.85 | -39.94 | 48.08 | -25.50 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 13.43 | 23.43 | 22.56 | 11.88 |